“Relax your tight end”, Prostate cancer screening isn’t what you think by Novartis
60% of American men mistakenly believe prostate cancer screening begins with an invasive rectal exam. That single misconception is responsible for millions of eligible men avoiding a test that, when it catches the disease early, carries a greater than 99% five-year survival rate. Novartis and Fallon decided the largest television audience in the world was […]
